Pain Therapeutics reported $21.34M in Operating Expenses for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Abbott ABT:US USD 8.76B 123M
Acelrx Pharmaceuticals ACRX:US USD 7.14M 7M
Amgen AMGN:US USD 3.91B 504M
Biogen BIIB:US USD 1.19B 1.45B
Cara Therapeutics CARA:US USD 34.66M 7.18M
Eisai 4523:JP JPY 176.54B 283M
Eli Lilly And LLY:US USD 5.27B 12.8M
Geron GERN:US USD 40.24M 12.2M
Johnson & Johnson JNJ:US USD 19.51B 1.54B
Merk MRK:US USD 10.97B 1.31B
Novartis NOVN:VX USD 10.67B 183M
Novavax NVAX:US USD 861.77M 192.88M
Pain Therapeutics PTIE:US USD 21.34M 1.43M
Pfizer PFE:US USD 13.23B 2.41B
Roche Holding ROG:VX 20.75B 3.26B